Sedamin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sedamin

Property Description
Active ingredient Atenolol
Form Oral tablet, Intravenous solution
Pharmacological class Beta-Adrenergic Receptor Antagonist (Beta-blocker)
Common purpose Stabilizing cardiovascular function
Origin Synthetic ethanolamine compound

Sedamin is a prescription-only medication whose active ingredient is Atenolol, formally classified as a Beta-Adrenergic Receptor Antagonist, commonly known as a beta-blocker. This type of synthetic drug is designed to manage the effects of adrenaline and other stress hormones on the body. Atenolol is considered a cardioselective beta1-blocking agent because it primarily targets the receptors predominantly found in the heart, a selectivity that is clinically recognized for reducing peripheral side effects compared to non-selective agents. It is utilized as a medicine to reduce the heart's workload.

The core composition of Sedamin centers entirely on the Atenolol molecule, confirming it as a single active ingredient product. It is available in two main dosage forms: the oral tablet (often film-coated) and a sterile solution for intravenous injection or infusion. This specific formulation is distinguished by its use in hemodynamically stable adult patients. While Sedamin is marketed as a single-agent therapy, the active substance Atenolol is also a frequent component in combination formulations alongside other agents, such as diuretics.

The overall purpose of using this beta-blocker is to promote sustained cardiovascular stability by precisely regulating the heart’s activity. Its mechanism decreases the heart's overall workload and oxygen demand by moderating the heart rate and reducing the force of the heart's contractions. Atenolol is widely utilized for its beta1-selective activity in various cardiovascular conditions. This fundamental regulatory effect makes the medicine essential in situations where consistent, lowered pressure and heart rate are required to maintain health.

Regulatory References

  1. National Library of Medicine (NLM)
  2. MedlinePlus: Atenolol Drug Information
  3. National Institutes of Health (NIH)
  4. Atenolol StatPearls Review

What side effects are possible with Sedamin?

Possible Side Effects and Safety Information

The regulatory safety profile for Sedamin, containing Atenolol, outlines specific adverse reactions classified by frequency and affected physiological systems. This information is based on official documents from government health authorities, defining the recognized risk profile.

Adverse Reaction Classification

Side effects are categorized based on their documented incidence in clinical use:

  • Common Reactions (Affecting up to 1 in 10 people): Fatigue and dizziness, slow heartbeat (bradycardia), and coldness of the extremities. Gastrointestinal disturbances such as nausea, vomiting, diarrhea, or constipation are also documented as common.
  • Uncommon Reactions (Affecting up to 1 in 100 people): Sleep disturbances, including nightmares, have been reported in this category.
  • Rare Reactions (Affecting up to 1 in 1,000 people): These include psychiatric effects such as confusion, psychoses, and hallucinations, as well as neurological issues like paresthesia and headache. Other rare effects include bronchospasm, visual disturbances, and various dermatological reactions like rash and alopecia. Sexual dysfunction is also listed as a rare effect.

Serious Adverse Reactions and Safety Constraints

Official labeling documents specific serious adverse events and safety constraints:

  • Serious Cardiac Events: The product information includes warnings regarding the potential for the worsening of existing heart failure or the development of second- or third-degree heart block.
  • Abrupt Cessation Risk: A critical safety constraint noted in regulatory documents is the risk of precipitating myocardial infarction or a severe angina exacerbation if the medicine is discontinued suddenly in patients with ischemic heart disease.
  • Population-Specific Notes: Safety statements exist for certain patient groups. For example, the medication may mask the symptoms of hypoglycemia in diabetic patients and the signs of thyrotoxicosis. Dosage adjustments are required for patients with documented renal impairment due to the drug's primary excretion pathway.

This official safety information provides a neutral description of the medicine's potential risks, separating expected effects from critical, less frequent events, consistent with regulatory safety reporting standards.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Sedamin (Acetaminophen/Paracetamol) is a medical emergency primarily due to the severe, potentially fatal risk of hepatotoxicity (liver damage). This risk is recognized in official regulatory documents as leading to acute liver failure and sometimes necessitating a liver transplant or resulting in death.

Documented Overdose Profile

Classification Key Information from Regulatory Sources
Life-Threatening Risk Severe, potentially fatal hepatic necrosis (liver cell death).
Symptom Latency Initial symptoms (nausea, vomiting, malaise) may be absent or non-specific. Severe signs of liver damage may be delayed 48 to 96 hours post-ingestion.
Risk Thresholds Toxicity risk increases with ingestion of specific supratherapeutic doses, typically over 7.5 to 10 grams within a 24-hour period, or from repeated high doses over time.

Critical Emergency Action

Official health warnings emphasize the need for immediate medical attention for any suspected or known overdose, regardless of how the person currently feels. Because early symptoms are unreliable and severe damage may be hidden for days, do not wait for visible signs of distress.

Contact a poison control center or emergency medical services right away. The specific antidote used to treat overdose is most effective when administered within the first eight hours after acute ingestion, making prompt action critical to patient outcome.

Therapeutic Uses of Sedamin

What Sedamin Treats: Main Uses and Benefits

Sedamin is applied across domains where short-term symptom management is appropriate, particularly in contexts involving heightened physiological stress and nervous activity. It is commonly used to help with symptoms related to sleeplessness and nervousness due to feelings of stress or fatigue. Its application includes use as a sleeping aid for occasional sleeplessness and as a sedative for nervousness and restlessness.

The product is applied in addressing symptom clusters that may become intense or disruptive, focusing on emotional and mental strain, as well as physical agitation. It is considered relevant in contexts involving symptoms of systemic imbalance, such as pronounced tiredness and malaise. By addressing these clusters, Sedamin generally helps support a more manageable experience during these episodic manifestations, contributing to improved comfort during symptomatic periods.

Quick Fact: Supports the management of Nervous Tension.

Eligibility and Restrictions for Use

Who Can and Cannot Use Sedamin?

The population eligibility for Sedamin (Atenolol) is strictly determined by official regulatory documents, primarily based on the patient's existing cardiovascular health, organ function, and age.

Category Official Regulatory Statement
Populations for whom use is allowed Adults approved for use in documented cardiac indications (e.g., hypertension, angina) [Source 1.5].
Populations for whom use is not recommended Pediatric Population (Safety and efficacy not established in children/adolescents) [Source 2.3]; Pregnancy (Due to risk of fetal growth restriction) [Source 1.5, 3.2].
Populations for whom use is contraindicated Patients with sinus bradycardia or severe slow heart rate, heart block greater than first degree, cardiogenic shock, overt cardiac failure, and severe asthma or COPD [Source 1.1, 2.2].

Age-Related Eligibility Rules: The medicine is not recommended for children and adolescents. Older adults may require a reduced dosage, particularly due to the likelihood of impaired renal function [Source 2.3].

Condition-Specific Eligibility: Renal impairment requires a mandatory dose adjustment because the drug is primarily eliminated by the kidneys [Source 1.5]. Caution is required in patients with diabetes mellitus, as the medicine may mask symptoms of hypoglycemia, and in patients with less severe peripheral vascular disturbances [Source 1.1].

Pregnancy and Lactation Eligibility: Use during pregnancy is officially not recommended. Use while lactating requires caution, as the medicine is excreted into breast milk and may pose a risk of bradycardia and hypoglycemia to the infant [Source 3.2, 2.1].

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Sedamin (Atenolol) is defined by its effects on heart function and its dependence on renal clearance, as detailed in regulatory documents. Officially documented interactions fall primarily into pharmacodynamic and exposure-altering categories.


Documented Interaction Restrictions

Category Documented Interaction Restriction
Contraindicated Combinations The co-administration of Disopyramide is strictly prohibited due to the risk of severe bradycardia and myocardial depression. Intravenous Verapamil is also formally contraindicated due to the documented risk of profound hypotension and cardiac failure.
Timing Requirements To ensure adequate absorption, regulatory labeling advises separating the administration of Atenolol from Aluminum or Magnesium Antacids by at least two hours.

Officially Documented Effects on Exposure

Interacting Substance Official Regulatory Description of Effect
Cimetidine Increases Atenolol's plasma levels and bioavailability.
Quinidine / Propafenone Increases Atenolol plasma concentrations by reducing its renal clearance.

Pharmacodynamic Synergism

Co-administration with other Calcium Channel Blockers (e.g., Diltiazem) and Antiarrhythmics carries an officially noted risk of additive effects, including severe bradycardia and heart block. With Clonidine, abrupt withdrawal requires caution; Atenolol must be discontinued several days prior to Clonidine cessation to prevent a documented rebound hypertensive crisis.

Mechanism of Action

GABA Receptor-Mediated Signaling Modulation

Sedamin's mechanism involves interaction with the gamma-aminobutyric acid ( GABA) system in the central nervous system. Constituents, such as Valerenic Acid, target the GABA A receptor complex. This interaction promotes the inhibitory function of the neurotransmitter GABA, leading to an increased flux of chloride ions across the neuronal membrane. The consequence of this enhanced GABA A receptor activity is a net increase in inhibitory synaptic transmission, primarily affecting circuits associated with arousal.


Neurotransmitter Catabolism and Monoamine Modulation

Further mechanistic activity involves the regulation of GABA concentration in the synapse. Derivatives are hypothesized to inhibit the enzyme system responsible for GABA catabolism, thereby sustaining the level of inhibitory signaling within targeted neural pathways. Additionally, components are suggested to modulate pathways involving monoamines like Serotonin (5- HT) and Dopamine. This broader regulatory effect influences the activity profile of several systemic central nervous system circuits.

Dosage and Administration Information

Sedamin (Atenolol) is administered via two officially approved routes: the oral tablet for chronic maintenance therapy and the intravenous solution for initial, acute intervention in supervised care settings. For oral use, the tablets are intended to be swallowed whole with water and may be taken with or without food, though consistently at the same time each day.

Standard adult dosing is based on the specific condition being managed. For hypertension, the usual starting dose is 50 mg taken once daily, with maintenance often ranging up to 100 mg daily. For angina pectoris, dosing may be initiated at 50 mg daily and escalated to 100 mg once daily after one week. The maximum dose for hypertension is generally 100 mg daily.

Specific adjustments to this regimen are mandated for certain populations. For patients with impaired kidney function, the maximum oral dose must be reduced based on creatinine clearance, such as a maximum of 50 mg daily for moderate impairment. Older adults may be started on a lower dose, such as 25 mg once daily. If an oral dose is missed, it should be skipped, and the patient should resume the normal schedule; the dose should never be doubled. A critical procedural constraint is that Sedamin must not be withdrawn abruptly; the dose must be gradually reduced over a period of one to two weeks before cessation.

Recent Clinical Evidence

Research evidence / Overview of studies for Sedamin

Evidence for Use in Managing High Blood Pressure (Hypertension)

Research exploring Atenolol (Sedamin) for high blood pressure has primarily used Randomized Controlled Trials (RCTs). These trials were designed to measure whether the medicine was associated with changes in both the upper (systolic) and lower (diastolic) blood pressure values. Larger, longer-term studies were also applied in research contexts involving fluctuating or unstable symptoms, specifically monitoring outcomes related to major cardiovascular events such as heart attack and stroke, as well as tracking outcomes related to overall survival.

The studies focused on adult patients with primary high blood pressure. Findings describe patterns observed in the studies where lower blood pressure values were recorded in groups compared to placebo. However, when studied alongside newer drug classes used for blood pressure management, findings were mixed regarding outcome measures in tracking long-term events like stroke and cardiovascular mortality.

Evidence for Use in Chronic Chest Pain (Angina Pectoris)

Research has explored the use of Atenolol in individuals experiencing chronic, stable chest pain due to heart disease. These trials examined outcomes related to physical discomfort, monitoring changes in the frequency of angina attacks and the participants' documentation of rescue medications required. The findings indicate patterns where the use of Atenolol was associated with changes in patient-reported outcomes describing perceived discomfort over short-term observation periods.

Evidence for Use Following a Heart Attack (Acute Myocardial Infarction)

The largest body of research supporting the study of Atenolol in this area comes from large-scale RCTs and subsequent meta-analyses focused on the wider class of beta-blocker medications. Research monitored outcomes capturing phases of heightened symptom activity, including changes in short-term and long-term survival status and the incidence of dangerous heart rhythm problems (arrhythmias). Studies observed patterns related to mortality and morbidity outcomes when the drug was administered in the acute phase of a heart attack and continued long-term. Comparative evidence is lacking regarding whether Atenolol differs in its long-term outcomes from other specific beta-blockers.

Understanding Research Gaps and Uncertainty

The available data for certain indications is more descriptive of immediate physiological changes than of the durability of results over decades. Data for certain groups, such as pregnant populations or children, remain insufficient within the regulatory research record. Subgroup findings are often uncertain due to smaller sample sizes.

Key Studies & References

  1. Atenolol - StatPearls (NIH Monograph detailing FDA approved indications and general evidence context)

Frequently Asked Questions (FAQ)

Common questions about Sedamin (FAQ)


Q: Is Sedamin a first-line treatment for the condition it addresses?

Official treatment guidelines for uncomplicated high blood pressure often recommend other types of medications as initial therapy. However, Sedamin (Atenolol) is generally recognized as an available option for initial treatment in specific patient groups, such as those with existing heart conditions like angina or a history of heart attack.


Q: What is the typical timeframe before noticing an effect from Sedamin?

According to official product information, the drug begins its main effect on the heart and blood pressure within one hour of taking a dose. This action is usually at its strongest between two to four hours after administration and lasts for at least 24 hours.


Q: How is the long-term safety profile of Sedamin described in official documents?

The long-term safety profile is described in regulatory documents based on extensive clinical trials and studies that monitor cardiovascular outcomes. These sources describe its role in managing symptoms and conditions, but some long-term research has led to evolving clinical recommendations regarding its use in specific patient populations, such as older adults with uncomplicated hypertension.


Q: Does Sedamin have a risk of dependence or addiction?

Sedamin (Atenolol) is not classified as a controlled substance by regulatory bodies, meaning it is not associated with abuse potential. Regulatory warnings state that the medicine should not be stopped suddenly, as abrupt cessation can cause serious cardiac events like a heart attack or severe chest pain exacerbation.


Q: Does Sedamin affect the ability to drive or operate machinery?

Official safety information advises caution when driving or operating machinery. If individuals experience common side effects such as dizziness, tiredness, or confusion, they should observe how the medication affects their alertness and coordination before engaging in these activities.


Q: Is Sedamin safe to take with alcohol, according to official information?

Regulatory documents warn that combining Sedamin with alcohol may lead to additive effects in lowering blood pressure. This is associated with an increased risk of feeling dizzy, lightheaded, or fainting.


Q: Does Sedamin require any special monitoring or regular blood tests?

Official guidelines indicate that monitoring pulse and blood pressure is generally used to help determine the appropriate dosage. Patients with impaired kidney function require specific attention and monitoring due to the drug's elimination pathway.


Q: Is it normal to feel no different when starting Sedamin?

Yes, it is common to not feel any immediate difference when starting treatment for high blood pressure or other silent conditions. Although you may not notice changes in your symptoms, official information confirms the drug is actively working to regulate your heart and blood pressure shortly after administration.


Q: Do Sedamin side effects typically go away over time?

Based on general patient experience described in official sources, common side effects such as dizziness or fatigue often lessen or resolve completely as the body becomes accustomed to the medication. This adjustment period often occurs over a period of a few days or weeks.


Q: Is Sedamin a controlled substance?

Sedamin, which contains Atenolol, is a prescription medication but is not classified as a controlled substance by regulatory authorities.


Q: Does Sedamin interact with common supplements like multivitamins or fish oil?

Information derived from drug regulatory sources suggests that when taken with multivitamins that contain minerals, the effect of Sedamin may potentially be decreased. Labeling advises separating the administration of Sedamin from mineral-containing multivitamins by at least two hours.


Q: Is Sedamin known to interact with caffeine?

Official information about the drug class indicates that caffeine, which is a central nervous system stimulant, may counteract the blood pressure-lowering effects of Sedamin. Regulatory information notes the importance of monitoring caffeine intake while using this medication.


Q: What information is provided about the effectiveness of Sedamin?

Regulatory documents support the effectiveness of Sedamin for its labeled uses, including the management of high blood pressure, chronic chest pain (angina), and certain outcomes following a heart attack. This information is derived from clinical trials that studied the drug’s effects.


Q: How does the action of Sedamin differ from similar medications?

Sedamin (Atenolol) is officially described as a cardioselective beta-blocker. This means its primary action is concentrated on the beta-1 receptors found predominantly in the heart. This specific targeting is recognized as a key characteristic that distinguishes it from non-selective beta-blockers.


Q: Is Sedamin a generic or a brand-name medication?

Sedamin is the brand name associated with the active ingredient, Atenolol. The generic version, Atenolol, is widely available, which is common practice for medications that have been on the market for an extended period.


Q: Is there a known Sedamin 'withdrawal' or discontinuation syndrome?

Regulatory labeling includes a serious warning against suddenly stopping the use of Sedamin. Abrupt cessation in patients with heart disease can lead to critical events like a heart attack or severe chest pain. The labeling specifies that the dosage should be gradually reduced over a period of one to two weeks before cessation.


Q: Are Sedamin side effects common or rare?

Official regulatory information classifies the likelihood of side effects into categories like common, uncommon, and rare. Events like fatigue and dizziness are reported in a notable percentage of patients, while very serious adverse events, such as severe heart rhythm problems, are reported as rare.


Q: What are the most frequently reported side effects of Sedamin?

Clinical studies listed in regulatory documents indicate that the most frequently reported side effects include tiredness, dizziness, slow heartbeat (bradycardia), coldness of the extremities, and lightheadedness when standing up (postural hypotension).


Q: Can Sedamin cause weight gain or weight loss?

Studies referenced by official sources suggest that a slight weight increase is possible during the initial months of treatment with this class of medication, typically averaging a few pounds. This change is generally not progressive over the long term.


Q: What are the considerations for using Sedamin during pregnancy?

Regulatory product information states that use during pregnancy is officially not recommended. This caution is due to the documented risk of restricted fetal growth and the potential for the infant to experience complications like a slow heart rate (bradycardia) or low blood sugar (hypoglycemia).


Q: What are the considerations for using Sedamin while breastfeeding?

Official information advises caution when using the drug while breastfeeding. This is because the active ingredient is known to be excreted into breast milk and may carry a risk of causing a slow heart rate or low blood sugar in the nursing infant.


Q: Can Sedamin affect the results of certain lab tests?

Official safety statements note that Sedamin may mask the physical signs of certain medical issues, such as low blood sugar (hypoglycemia) in patients with diabetes or symptoms of an overactive thyroid (thyrotoxicosis). It is also documented that this class of medication may alter certain blood fat levels (serum lipid profiles).


Q: Is there any difference between the brand and generic versions of Sedamin?

Regulatory agencies require generic versions of Atenolol to meet rigorous bioequivalence standards. These standards ensure that the generic product contains the exact same active ingredient and is expected to work in the body the same way as the brand-name product.


Q: Is Sedamin commonly associated with drowsiness or sleepiness?

Yes, common side effects listed in official documents include fatigue and lightheadedness. While less frequent than general tiredness, drowsiness and sleepiness are also reported as potential adverse events.


Q: Can Sedamin cause changes in mood or emotional state?

Official regulatory information notes that depression is a commonly reported adverse event associated with the medication. More severe psychiatric effects, such as confusion and hallucinations, have been reported in the rare adverse reaction category.


Q: Does Sedamin affect sleep patterns or cause insomnia?

Yes, sleep disturbances, including nightmares and dreaming, are included in the official safety profile as an uncommon side effect.


Q: Can Sedamin cause changes in blood pressure or heart rate?

The primary therapeutic action of the drug is to moderate heart rate and lower blood pressure. However, common side effects documented in official sources include an unintended slow heart rate (bradycardia) and abnormally low blood pressure (hypotension).


Q: Is Sedamin safe for older adults or geriatric patients?

Official regulatory documents state that the use of Sedamin in older adults requires caution. Due to the increased likelihood of reduced kidney function in this population, official information indicates that a lower starting dose may be considered, particularly due to the role of the kidneys in clearing the drug from the body.


How should Sedamin be stored and disposed of?

How to Store and Dispose of Sedamin?

The storage and handling of Sedamin (Atenolol) must strictly follow official regulatory requirements to ensure product stability and safety.

Required Storage Conditions

Sedamin must be stored at a temperature not exceeding 25 C (77 F), away from excess heat and moisture, in a cool, dry place. The product must be protected from light by being kept in the original carton and, if applicable, the container must remain tightly closed. The intravenous solution, if diluted, has a documented 48-hour stability period if not used immediately.

Child Safety and Disposal

It is an official regulatory requirement to keep this medicine out of the sight and reach of children.

Disposal of any unused or expired product must be done in accordance with local requirements. The medicine should not be allowed to enter sewers, surface water, or ground water. For home disposal, if a take-back program is unavailable, the medication should be mixed with an unappealing substance, sealed, and discarded in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sedamin found in:

A-Z Index: